The present invention regards cancer-specific control sequences that direct expression of a polynucleotide encoding a therapeutic gene product for treatment of the cancer. Specifically, the invention encompasses breast cancer-specific and ovarian cancer-specific control sequences. Two breast cancer-specific sequences utilize specific regions of fatty acid synthase and claudin 4 promoters, particularly in combination with a two-step transcription amplification sequence and/or a post-transcriptional control sequence. Two ovarian cancer-specific sequences utilize specific regions of hTERT and survivin promoters, particularly in combination with a two-step transcription amplification sequence and/or a post-transcriptional control sequence. In more particular embodiments, these polynucleotides are administered in combination with liposomes.
申请公布号
WO2008070448(A2)
申请公布日期
2008.06.12
申请号
WO2007US85223
申请日期
2007.11.20
申请人
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM;HUNG, MIEN-CHIE;XIE, XIAOMING;LANG, JING-YU